- $1.73bn
- $1.63bn
- $124.46m
- 36
- 12
- 78
- 37
Annual income statement for Ardelyx, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 5.28 | 7.57 | 10.1 | 52.2 | 124 |
Cost of Revenue | |||||
Gross Profit | 4.68 | 7.43 | 9.1 | 48 | 107 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 96.5 | 98.4 | 164 | 116 | 188 |
Operating Profit | -91.3 | -90.8 | -154 | -63.8 | -63.3 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -94.6 | -94.3 | -158 | -67.2 | -65.5 |
Provision for Income Taxes | |||||
Net Income After Taxes | -94.9 | -94.3 | -158 | -67.2 | -66.1 |
Net Income Before Extraordinary Items | |||||
Net Income | -94.9 | -94.3 | -158 | -67.2 | -66.1 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -94.9 | -94.3 | -158 | -67.2 | -66.1 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -1.47 | -1.05 | -1.48 | -0.424 | -0.3 |